EXAS vs MCHPP · rev $2.76B vs rev $4.40B
EXACT Sciences Corporation (EXAS) versus Microchip Technology Incorporated (MCHPP) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Microchip Technology Incorporated (MCHPP) is a semiconductors company listed on US.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported MCHPP revenue for 2025-03-31 was $4.40B. Net income was -$500.0K. Revenue was down 42.3% from 2024-03-31 to 2025-03-31. MCHPP currently screens at market cap $0.
EXAS currently screens at market cap $20.03B. MCHPP currently screens at market cap $0.
Not investment advice. Open the EXAS and MCHPP stock pages for the full models.
Not investment advice.